Sign in
Home
Biotech News
Conferences
Technology Conferences
Biotech Conferences
CoronaVirus
Precision Vaccinations
Internet News
Research
Reverse Splits
Reverse Split News
Reverse Split Watch List
Reverse Stock Split List
Upcoming Reverse Stock Split List
More Finance Channels
Beverage Stocks
Blockchain Stocks
Gold Stocks
Marijuana Stocks
Psychedelic Stocks
Stand Down – Wall Street Bears
Tiki Hut Fund
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Privacy Policy
Password recovery
Recover your password
your email
Search
Thursday, May 2, 2024
Sign in / Join
Contact Us
Featured News
Free Weekly Newsletter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Internet | Biotech Stock Review
Home
Biotech News
Conferences
Technology Conferences
Biotech Conferences
CoronaVirus
Precision Vaccinations
Internet News
Research
Reverse Splits
Reverse Split News
Reverse Split Watch List
Reverse Stock Split List
Upcoming Reverse Stock Split List
More Finance Channels
Beverage Stocks
Blockchain Stocks
Gold Stocks
Marijuana Stocks
Psychedelic Stocks
Stand Down – Wall Street Bears
Tiki Hut Fund
Home
Authors
Posts by Editor / Curator
Editor / Curator
916 POSTS
0 COMMENTS
Psychedelic Stock Review
Billionaire, Point 72’s Steve Cohen, Continues to Support Psychedelic Research.
Editor / Curator
-
June 19, 2023
Biotech News
Scientists Pinpoint Location of Plaque Ruptures..
Editor / Curator
-
June 16, 2023
2021 Watch List
Hepion Pharmaceuticals (HEPA) Announces Passing of Key Safety Milestone in Phase...
Editor / Curator
-
June 16, 2023
Psychedelic News
Psycheceutical’s (BWVI) NeuroDirect™ Ketamine can Help Alleviate Headaches and Migraines Within...
Editor / Curator
-
June 16, 2023
2023 Watch List
Psycheceutical Bioscience (BWVI) Secures Funding for Clinical Trials
Editor / Curator
-
June 13, 2023
2023 Watch List
Hepion Pharma (HEPA). Artificial Intelligence (AI) to Speed Drug Development.
Editor / Curator
-
June 12, 2023
Client
Acquisition of Certain Minerva-Rockdale Oil and Gas Leases and Field Equipment...
Editor / Curator
-
June 12, 2023
Client
Principal Solar Comments on SEC Action
Editor / Curator
-
June 9, 2023
2023 Watch List
Pressure Bioscience (PBIO) Meets Ohio State University. Pressure Testing on Food...
Editor / Curator
-
June 8, 2023
2023 Watch List
Adding Pressure BioSciences (PBIO) $0.80 to Watch List.
Editor / Curator
-
June 7, 2023
1
...
14
15
16
...
92
Page 15 of 92
Latest article
Institutional Analyst Newsletter. Citius (CTXR), GeoVax (GOVX.
Institutional Analyst Newsletter
Editor / Curator
-
May 2, 2024
DERBY WEEKEND - WE'RE HEADED TO TAMPA!HAT'S ON, DRINK'S UPADDING CITIUS PHARMA (CTXR) $0.66, TO WATCHLISTUPDATING GEOVAX LABS (GOVX) $1.43OUR $26...
Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.
2024 Watch List
Editor / Curator
-
April 29, 2024
Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!
Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet.
2024 Watch List
Editor / Curator
-
April 27, 2024
CRANFORD, N.J., April 26, 2024 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization...
Edit with Live CSS